Privacy

Privacy Policy
The Company Istituto Lusofarmaco d’Italia S.p.A. (“Company”, or “we”) takes its users’ privacy very seriously and undertakes to comply in full with the applicable law (Regulation (EU) 2016/679 – hereinafter defined as the “GDPR”). This document (“Privacy Policy”) provides information on how the personal data collected by the Company through this website (“Website”) are processed, and constitutes “an information notice to the data subjects” under the terms of art. 13 of the GDPR...

Read More »

Cookie Policy
The website uses cookies to facilitate and personalise the user’s browsing experience; by browsing the Website, the user agrees to the use of cookies in compliance with this document. This notice represents an extension of the cookie notification banner displayed when users first connect to the home page of this Website. There exist two categories of cookies: technical cookies: these are necessary for correct functioning of a website and to permit browsing by the user; without...

Read More »

Our products

Lusofarmaco can claim extensive know-how in various therapeutic areas: cardiovascular and respiratory diseases, antibiotic therapy, neuropsychiatry and gynecology.

Research & Development

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.

Pharmacovigilance

Pharmacovigilance: what does it mean to monitor drugs?

Registered Office:
Milanofiori – Strada 6, Edificio L – 20089 Rozzano (MI)
Tel. 02-516555.1 - Fax 02-516555.249

Registration No. In Registrar Of Companies: 00714810157
Registrar Of Companies' Office: Milano
Registered Capital: € 130.000 I.V.
Capital Reported In Last Financial Statement: € 130.000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl

SITEMAP

Copyright 2021 Istituto Lusofarmaco D'Italia S.p.A.